Ginsenoside Rg1 ameliorates blood–brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release
During the traumatic brain injury (TBI), improved expression of circulatory miR-21 serves as a diagnostic feature. Low levels of exosome-miR-21 in the brain can effectively improve neuroinflammation and blood–brain barrier (BBB) permeability, reduce nerve apoptosis, restore neural function and ameli...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/db6f80dbcf4a41e5aa7bc2bd0fbdb55f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:db6f80dbcf4a41e5aa7bc2bd0fbdb55f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:db6f80dbcf4a41e5aa7bc2bd0fbdb55f2021-12-02T05:01:21ZGinsenoside Rg1 ameliorates blood–brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release2211-383510.1016/j.apsb.2021.03.032https://doaj.org/article/db6f80dbcf4a41e5aa7bc2bd0fbdb55f2021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2211383521001040https://doaj.org/toc/2211-3835During the traumatic brain injury (TBI), improved expression of circulatory miR-21 serves as a diagnostic feature. Low levels of exosome-miR-21 in the brain can effectively improve neuroinflammation and blood–brain barrier (BBB) permeability, reduce nerve apoptosis, restore neural function and ameliorate TBI. We evaluated the role of macrophage derived exosomes-miR-21 (M-Exos-miR-21) in disrupting BBB, deteriorating TBI, and Rg1 interventions. IL-1β-induced macrophages (IIM)-Exos-miR-21 can activate NF-κB signaling pathway and induce the expressions of MMP-1, -3 and -9 and downregulate the levels of tight junction proteins (TJPs) deteriorating the BBB. Rg1 reduced miR-21-5p content in IIM-Exos (RIIM-Exos). The interaction of NMIIA–HSP90 controlled the release of Exos-miR-21, this interaction was restricted by Rg1. Rg1 could inhibit the Exos-miR-21 release in peripheral blood flow to brain, enhancing TIMP3 protein expression, MMPs proteolysis, and restricting TJPs degradation thus protected the BBB integrity. Conclusively, Rg1 can improve the cerebrovascular endothelial injury and hold the therapeutic potential against TBI disease.Kefeng ZhaiHong DuanWei WangSiyu ZhaoGhulam Jilany KhanMengting WangYuhan ZhangKiran ThakurXuemei FangChao WuJianbo XiaoZhaojun WeiElsevierarticleTraumatic brain injuryExosomeMiRNA-21Blood–brain barrierGinsenoside Rg1Nonmuscle myosin IIATherapeutics. PharmacologyRM1-950ENActa Pharmaceutica Sinica B, Vol 11, Iss 11, Pp 3493-3507 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Traumatic brain injury Exosome MiRNA-21 Blood–brain barrier Ginsenoside Rg1 Nonmuscle myosin IIA Therapeutics. Pharmacology RM1-950 |
spellingShingle |
Traumatic brain injury Exosome MiRNA-21 Blood–brain barrier Ginsenoside Rg1 Nonmuscle myosin IIA Therapeutics. Pharmacology RM1-950 Kefeng Zhai Hong Duan Wei Wang Siyu Zhao Ghulam Jilany Khan Mengting Wang Yuhan Zhang Kiran Thakur Xuemei Fang Chao Wu Jianbo Xiao Zhaojun Wei Ginsenoside Rg1 ameliorates blood–brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release |
description |
During the traumatic brain injury (TBI), improved expression of circulatory miR-21 serves as a diagnostic feature. Low levels of exosome-miR-21 in the brain can effectively improve neuroinflammation and blood–brain barrier (BBB) permeability, reduce nerve apoptosis, restore neural function and ameliorate TBI. We evaluated the role of macrophage derived exosomes-miR-21 (M-Exos-miR-21) in disrupting BBB, deteriorating TBI, and Rg1 interventions. IL-1β-induced macrophages (IIM)-Exos-miR-21 can activate NF-κB signaling pathway and induce the expressions of MMP-1, -3 and -9 and downregulate the levels of tight junction proteins (TJPs) deteriorating the BBB. Rg1 reduced miR-21-5p content in IIM-Exos (RIIM-Exos). The interaction of NMIIA–HSP90 controlled the release of Exos-miR-21, this interaction was restricted by Rg1. Rg1 could inhibit the Exos-miR-21 release in peripheral blood flow to brain, enhancing TIMP3 protein expression, MMPs proteolysis, and restricting TJPs degradation thus protected the BBB integrity. Conclusively, Rg1 can improve the cerebrovascular endothelial injury and hold the therapeutic potential against TBI disease. |
format |
article |
author |
Kefeng Zhai Hong Duan Wei Wang Siyu Zhao Ghulam Jilany Khan Mengting Wang Yuhan Zhang Kiran Thakur Xuemei Fang Chao Wu Jianbo Xiao Zhaojun Wei |
author_facet |
Kefeng Zhai Hong Duan Wei Wang Siyu Zhao Ghulam Jilany Khan Mengting Wang Yuhan Zhang Kiran Thakur Xuemei Fang Chao Wu Jianbo Xiao Zhaojun Wei |
author_sort |
Kefeng Zhai |
title |
Ginsenoside Rg1 ameliorates blood–brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release |
title_short |
Ginsenoside Rg1 ameliorates blood–brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release |
title_full |
Ginsenoside Rg1 ameliorates blood–brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release |
title_fullStr |
Ginsenoside Rg1 ameliorates blood–brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release |
title_full_unstemmed |
Ginsenoside Rg1 ameliorates blood–brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release |
title_sort |
ginsenoside rg1 ameliorates blood–brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes mir-21 release |
publisher |
Elsevier |
publishDate |
2021 |
url |
https://doaj.org/article/db6f80dbcf4a41e5aa7bc2bd0fbdb55f |
work_keys_str_mv |
AT kefengzhai ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release AT hongduan ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release AT weiwang ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release AT siyuzhao ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release AT ghulamjilanykhan ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release AT mengtingwang ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release AT yuhanzhang ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release AT kiranthakur ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release AT xuemeifang ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release AT chaowu ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release AT jianboxiao ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release AT zhaojunwei ginsenosiderg1amelioratesbloodbrainbarrierdisruptionandtraumaticbraininjuryviaattenuatingmacrophagesderivedexosomesmir21release |
_version_ |
1718400859435433984 |